Neurological Outcome in Patients of Traumatic Subarachnoid Haemorrhage

February 25, 2014 updated by: Macmillan Research Group UK

Incidence and Outcomes of Traumatic Subarachnoid Haemorrhage Patients: A Cross Sectional Study

Traumatic brain injury is common cause of morbidity and mortality worldwide. Incidence and pattern of traumatic brain injury varies in developed and developing countries. Subarachnoid haemorrhage refers to blood in subarachnoid space that lies between arachnoid and piameninges, covering brain. It is often associated with concurrent intracranial injury component. Individuals at higher risk for tSAH are those who are at higher risk for blunt head trauma. This includes adolescents, low-income individuals, men, and individuals with a history of substance abuse. The investigators present study aims to investigate prognostic factors associated with the neurological outcome among patients of post traumatic SAH.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

117

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

traumatic subarachnoid haemorrhage

Description

Inclusion Criteria:

  • All patients of traumatic subarachnoid haemorrhage

Exclusion Criteria:

  • Metabolic disorder
  • Altered coagulation profile
  • Cardiac disease
  • Co- morbid illness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
traumatic subarachnoid haemorrhage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Level of consciousness measured by Glasgow coma scale
Time Frame: Change from baseline to one month
Change from baseline to one month

Secondary Outcome Measures

Outcome Measure
Time Frame
appearance of subarachnoid hemorrhage on CT measured by Fisher Grading
Time Frame: Change from baseline to one month
Change from baseline to one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Neha Sharma, PhD, Macmillan Research Group UK
  • Study Director: Virendra D Sinha, M Ch, SMS Medical College & Hospital, Jaipur
  • Principal Investigator: Manish Agrawal, M Ch, SMS Medical College & Hospital, Jaipur

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (Actual)

April 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

February 6, 2014

First Submitted That Met QC Criteria

February 25, 2014

First Posted (Estimate)

February 27, 2014

Study Record Updates

Last Update Posted (Estimate)

February 27, 2014

Last Update Submitted That Met QC Criteria

February 25, 2014

Last Verified

February 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Subarachnoid Haemorrhage

3
Subscribe